MapLight Therapeutics Inc logo

MapLight Therapeutics Inc

MPLT
Healthcare|Biotechnology|USA
$39.28
-0.48 (-1.21%)
Tangible Book
$8.84

Analyst Estimates

annual
{ "date": [ "202612", "202712", "202812" ], "revenue_estimate": [ null, null, null ], "net_income_estimate": [ null, null, null ], "ebit_estimate": [ -189.5, -154, -195.5 ], "ebitda_estimate": [ -267.4, -285.5, -289 ], "per_share_eps_estimate": [ -5.285, -5.245, -4.47 ], "eps_nri_estimate": [ -5.285, -5.245, -4.47 ], "dividend_estimate": [ null, null, null ], "operating_cash_flow_per_share_estimate": [ null, null, null ], "book_value_per_share_estimate": [ null, null, null ], "pretax_income_estimate": [ null, null, null ], "roa_estimate": [ null, null, null ], "roe_estimate": [ null, null, null ], "gross_margin_estimate": [ null, null, null ], "pettm_estimate": [ 0, 0, 0 ], "operating_cash_flow_estimate": [ null, null, null ], "long_term_growth_rate_mean": 34.81, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": 34.81, "future_eps_nri_estimate_growth": 34.81, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": -18.34, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }
quarterly
{ "date": [ "202606", "202609", "202612", "202703", "202706", "202709", "202712" ], "revenue_estimate": [ null, null, null, null, null, null, null ], "net_income_estimate": [ null, null, null, null, null, null, null ], "ebit_estimate": [ null, null, null, null, null, null, null ], "ebitda_estimate": [ null, null, null, null, null, null, null ], "per_share_eps_estimate": [ -1.43, -1.26, -1.27, -1.35, -1.39, -1.32, -1.22 ], "eps_nri_estimate": [ -1.43, -1.26, -1.27, -1.35, -1.39, -1.32, -1.22 ], "dividend_estimate": [ null, null, null, null, null, null, null ], "operating_cash_flow_per_share_estimate": [ null, null, null, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null, null, null ], "pretax_income_estimate": [ null, null, null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null, null, null ], "roe_estimate": [ null, null, null, null, null, null, null ], "gross_margin_estimate": [ null, null, null, null, null, null, null ], "pettm_estimate": [ 0, 0, 0, 0, 0, 0, 0 ], "operating_cash_flow_estimate": [ null, null, null, null, null, null, null ], "long_term_growth_rate_mean": 34.81, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": 34.81, "future_eps_nri_estimate_growth": 34.81, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": -18.34, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }

News

2026-07-10 10:02:02
2026-06-25 11:33:43
2026-06-23 13:44:47
2026-06-22 18:00:54
2026-06-22 11:52:26